Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siu Ki Chan

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|May 3, 2006
Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileumSiu Ki Chan, John A Rudd
Surgical Neurology|October 2, 2007
Triology of neurosurgical complications after radiotherapy for nasopharyngeal carcinomaGilberto Ka Kit Leung, Siu Ki Chan, Kwan Ngai Hung
The American Journal of Surgical Pathology|June 30, 2009
IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing diseaseSiu-Ki Chan, Wah Cheuk, Kwan-Tsz Chan, et al.
Histopathology|November 27, 2014
GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroupsYun Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
Annals of Surgical Oncology|April 19, 2014
A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinomaYun-Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
British Journal of Cancer|July 28, 2020
The significance of highlighting the oestrogen receptor low category in breast cancerIvan K Poon, Julia Y Tsang, Joshua Li, et al.
Histopathology|November 2, 2018
Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breastJoshua Li, Wai-Yee Ho, Julia Y S Tsang, et al.
Annals of Surgical Oncology|February 10, 2015
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast CancerMaribel D Lacambra, Julia Y S Tsang, Yun-Bi Ni, et al.
Oncotarget|December 18, 2015
FGFR1 is an adverse outcome indicator for luminal A breast cancersYu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Pathology|September 21, 2020
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancerHuda Razvi, Julia Y Tsang, Ivan K Poon, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|May 3, 2006
Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileumSiu Ki Chan, John A Rudd
Surgical Neurology|October 2, 2007
Triology of neurosurgical complications after radiotherapy for nasopharyngeal carcinomaGilberto Ka Kit Leung, Siu Ki Chan, Kwan Ngai Hung
The American Journal of Surgical Pathology|June 30, 2009
IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing diseaseSiu-Ki Chan, Wah Cheuk, Kwan-Tsz Chan, et al.
Histopathology|November 27, 2014
GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroupsYun Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
Annals of Surgical Oncology|April 19, 2014
A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinomaYun-Bi Ni, Julia Y S Tsang, Siu Ki Chan, et al.
British Journal of Cancer|July 28, 2020
The significance of highlighting the oestrogen receptor low category in breast cancerIvan K Poon, Julia Y Tsang, Joshua Li, et al.
Histopathology|November 2, 2018
Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breastJoshua Li, Wai-Yee Ho, Julia Y S Tsang, et al.
Annals of Surgical Oncology|February 10, 2015
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast CancerMaribel D Lacambra, Julia Y S Tsang, Yun-Bi Ni, et al.
Oncotarget|December 18, 2015
FGFR1 is an adverse outcome indicator for luminal A breast cancersYu-Jie Shi, Julia Y S Tsang, Yun-Bi Ni, et al.
Pathology|September 21, 2020
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancerHuda Razvi, Julia Y Tsang, Ivan K Poon, et al.
Pageof 6